Harbison, Carole E.
Alnylam Pharmaceuticals (United States)
2 papers on CoChatORCID 0000-0003-1696-3859
Most cited papers
- Verified
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
Janas, M. M., Schlegel, M. K., Harbison, C. E., Yilmaz, V. O., Jiang, Y., Parmar, R., Zlatev, I., Castoreno, A., Xu, H., Shulga-Morskaya, S., et al. (2018) · Nature Communications
RNA Interference and Gene DeliveryDrug-Induced Hepatotoxicity and Protection
Cited by 279
- Verified
Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5
Harbison, C. E., Weichert, W. S., Gurda, B. L., Chiorini, J. A., Agbandje-McKenna, M., & Parrish, C. R. (2012) · Journal of General Virology
Virus-based gene therapy researchMonoclonal and Polyclonal Antibodies Research
Cited by 54
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free